Treatment with buntanetap, a small molecule being developed by Annovis Bio for neurodegenerative diseases, improved cognitive function in people…
Articles by Margarida Maia, PhD
Treatment with SNK01, a natural killer (NK) cell therapy being developed by NKGen Biotech, appears safe and well tolerated…
The U.S. Food and Drug Administration (FDA) has granted breakthrough device designation to Quanterix’s experimental blood test measuring p-Tau…
A Phase 3 clinical trial of AVP-786Â failed to meet its main goal of easing agitation in adults with dementia…
T3D-959, an oral medication in the pipeline of T3D Therapeutics, outperformed a placebo at improving cognitive function in…
The U.S. Food and Drug Administration (FDA) has granted full approval to Eisai and Biogen’s Leqembi (lecanemab), the first…
Cognitive benefits were reported in nearly half of the Alzheimer’s disease patients given simufilam for one year in a clinical…
INmune Bio received the green light for MINDFul, its Phase 2 trial of XPro1595 — an experimental treatment for…
Acumen Pharmaceuticals’ investigational antibody ACU193 has been granted fast track status by the U.S. Food and Drug Administration (FDA), which…
COR588, Quince Therapeutics’ investigational oral small molecule for mild to moderate Alzheimer’s disease, appears to be safe and well…